Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Dunham

Dunham Small Cap Growth Fund Dunham Small Cap Growth Fund Class N (DNDGX)

Ticker DNDGX · · Holdings as of Jul 31, 2026

Expense ratio
1.24%$124/yr per $10k
Net assets
$79.9Mall share classes
Holdings
111

Bottom line

Is DNDGX a good fund? The bottom line

DNDGX is a share class of Dunham Small Cap Growth Fund, an actively managed small-cap mutual fund from Dunham.

It charges 1.24% — about $124 a year on every $10,000 invested, more expensive than 74% of small-cap funds we track.

With $79.9 million in net assets and 111 holdings, its largest position is Fidelity Colchester Street Trust (3.1%) and the top 10 make up 17.1% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.24%)
  • High turnover (153% a year) can mean more taxable distributions

Updated Nov 19, 2026

What DNDGX invests in

The Fund seeks to maximize capital appreciation.

The Fund?s Sub-Adviser seeks to achieve the Fund?s investment objective by investing primarily in domestic growth-oriented, small-capitalization or ?small-cap? common stocks of companies traded on U.S. stock exchanges or in the over-the-counter market using its proprietary stock selection process. Under normal market conditions, the Fund invests at least 80% of its assets (defined as net assets plus borrowing for investment purposes) in small cap companies. The Fund defines small capitalization companies as those companies whose market capitalizations are equal to or less than the largest company in the Russell 2000 Index during the most recent 12-month period. For the most recent annual reconstitution published as of June 2025, the maximum market capitalization of companies in the Russell 2000 Index was approximately $15.7 billion, which will vary daily. The Sub-Adviser attempts to…

From the fund's prospectus (filed Feb 27, 2026).

DNDGX performance

Fund calendar-year total returns, 2016–2025 2016: +6.2%; 2017: +30.0%; 2018: −3.8%; 2019: +25.1%; 2020: +68.5%; 2021: +5.3%; 2022: −33.0%; 2023: +21.7%; 2024: +14.1%; 2025: +12.3% +6% 2016 +30% 2017 −4% 2018 +25% 2019 +69% 2020 +5% 2021 −33% 2022 +22% 2023 +14% 2024 +12% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
DNDGX———
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of

Full DNDGX performance history →

What DNDGX costs

On a $10,000 investment, DNDGX's 1.24% expense ratio costs about $124 a year. The prospectus estimates $1,500 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full DNDGX fee table →

DNDGX top 10 holdings

#Holding% of fund
1Fidelity Colchester Street Trust3.13%
2Esco Technologies Inc1.82%
3Hexcel Corp1.79%
4Fulton Financial Corp1.57%
5Establishment Labs Holdings Inc1.56%
6Valmont Industries Inc1.55%
7Angiodynamics Inc1.47%
8Imax Corp1.42%
9Kodiak Gas Services Inc1.39%
10Repligen Corp1.38%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 17.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to DNDGX

More funds like DNDGX →

DNDGX FAQ

What is the expense ratio of DNDGX?
DNDGX's expense ratio is 1.24%, which works out to about $124 a year for every $10,000 invested. The prospectus estimates total costs of $1,500 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DNDGX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.24%); high turnover (153% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does DNDGX hold?
DNDGX's largest holdings are Fidelity Colchester Street Trust (3.1%), Esco Technologies Inc (1.8%), Hexcel Corp (1.8%), Fulton Financial Corp (1.6%), Establishment Labs Holdings Inc (1.6%). It holds 111 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Does DNDGX have a sales load?
No. DNDGX has no front-end sales charge.
Who manages DNDGX?
DNDGX is offered by Dunham through Dunham Funds.